An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Show Description +

Ryan Rich, MD, explains the latest safety data on brolucizumab, the right patient selection criteria, and how to council patients carefully.

Posted: 2/23/2021

Keywords:

brolucizumab

•

retina-meeting-recap

Up Next

Name: An Update on Brolucizumab One Year Later
Uploaded: 2021-02-23T19:06:51+00:00
Description: Ryan Rich, MD, explains the latest safety data on brolucizumab, the right patient selection criteria, and how to council patients carefully.

The Benefits of Anti-VEGF for Advanced Vision Loss in Wet AMD

Dennis Han, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

An Update on Surgical Approaches to Gene and Cell Therapies

Allen C. Ho, MD, Timothy G. Murray, MD, MBA

ROP in the Era of Anti-VEGF

R.V. Paul Chan, MD, MSc, MBA, FACS, Timothy G. Murray, MD, MBA

Advancements in Retinal Detachment Repair

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

Timothy W. Olsen, MD, Timothy G. Murray, MD, MBA

Back to All Videos

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Ryan Rich, MD, explains the latest safety data on brolucizumab, the right patient selection criteria, and how to council patients carefully.

Posted: 2/23/2021

Keywords:

brolucizumab

•

retina-meeting-recap

Please log in to leave a comment.

More From ARDS: 2021 Coverage

The Benefits of Anti-VEGF for Advanced Vision Loss in Wet AMD

Dennis Han, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

Meeting Coverage:

Aspen Retinal Detachment Society

An Update on Brolucizumab One Year Later

Up Next

An Update on Brolucizumab One Year Later

More From ARDS: 2021 Coverage